152 related articles for article (PubMed ID: 22186957)
21. High-throughput compatible fluorescence resonance energy transfer-based assay to identify small molecule inhibitors of AMSH deubiquitinase activity.
Arnst JL; Davies CW; Raja SM; Das C; Natarajan A
Anal Biochem; 2013 Sep; 440(1):71-7. PubMed ID: 23747283
[TBL] [Abstract][Full Text] [Related]
22. TR-FRET-based high-throughput screening assay for identification of UBC13 inhibitors.
Madiraju C; Welsh K; Cuddy MP; Godoi PH; Pass I; Ngo T; Vasile S; Sergienko EA; Diaz P; Matsuzawa S; Reed JC
J Biomol Screen; 2012 Feb; 17(2):163-76. PubMed ID: 22034497
[TBL] [Abstract][Full Text] [Related]
23. High-Throughput Spectral and Lifetime-Based FRET Screening in Living Cells to Identify Small-Molecule Effectors of SERCA.
Schaaf TM; Peterson KC; Grant BD; Bawaskar P; Yuen S; Li J; Muretta JM; Gillispie GD; Thomas DD
SLAS Discov; 2017 Mar; 22(3):262-273. PubMed ID: 27899691
[TBL] [Abstract][Full Text] [Related]
24. High-Throughput Screening and Triage Assays Identify Small Molecules Targeting c-MYC in Cancer Cells.
Kallal LA; Waszkiewicz A; Jaworski JP; Della Pietra A; Berrodin T; Brady P; Jurewicz AJ; Zeng X; Payne L; Medina JR; Doepner-Buser C; Mangatt B
SLAS Discov; 2021 Feb; 26(2):216-229. PubMed ID: 33482073
[TBL] [Abstract][Full Text] [Related]
25. Identification of small molecule inhibitors of the mitotic kinase haspin by high-throughput screening using a homogeneous time-resolved fluorescence resonance energy transfer assay.
Patnaik D; Jun Xian ; Glicksman MA; Cuny GD; Stein RL; Higgins JM
J Biomol Screen; 2008 Dec; 13(10):1025-34. PubMed ID: 18978305
[TBL] [Abstract][Full Text] [Related]
26. High-throughput TR-FRET assays for identifying inhibitors of LSD1 and JMJD2C histone lysine demethylases.
Yu V; Fisch T; Long AM; Tang J; Lee JH; Hierl M; Chen H; Yakowec P; Schwandner R; Emkey R
J Biomol Screen; 2012 Jan; 17(1):27-38. PubMed ID: 21859682
[TBL] [Abstract][Full Text] [Related]
27. A dual-readout F2 assay that combines fluorescence resonance energy transfer and fluorescence polarization for monitoring bimolecular interactions.
Du Y; Nikolovska-Coleska Z; Qui M; Li L; Lewis I; Dingledine R; Stuckey JA; Krajewski K; Roller PP; Wang S; Fu H
Assay Drug Dev Technol; 2011 Aug; 9(4):382-93. PubMed ID: 21395401
[TBL] [Abstract][Full Text] [Related]
28. In pursuit of synthetic modulators for the orphan retina-specific nuclear receptor NR2E3.
Qin Q; Knapinska A; Dobri N; Madoux F; Chase P; Hodder P; Petrukhin K
J Ocul Pharmacol Ther; 2013 Apr; 29(3):298-309. PubMed ID: 23098562
[TBL] [Abstract][Full Text] [Related]
29. A Novel Fluorescence Resonance Energy Transfer-Based High-Throughput Screening Method for Generation of Lysozyme with Improved Antimicrobial Activity against
Wen S; Yao D; Liu X; Wang F
J Agric Food Chem; 2019 Nov; 67(45):12584-12589. PubMed ID: 31640344
[TBL] [Abstract][Full Text] [Related]
30. Identification of novel scaffolds for IκB kinase beta inhibitor via a high-throughput screening TR-FRET assay.
Oh KS; Lee S; Choi JK; Lee BH
Comb Chem High Throughput Screen; 2010 Nov; 13(9):790-7. PubMed ID: 20615197
[TBL] [Abstract][Full Text] [Related]
31. High-throughput screening of low molecular weight NS3-NS4A protease inhibitors using a fluorescence resonance energy transfer substrate.
Sudo K; Yamaji K; Kawamura K; Nishijima T; Kojima N; Aibe K; Shimotohno K; Shimizu Y
Antivir Chem Chemother; 2005; 16(6):385-92. PubMed ID: 16329285
[TBL] [Abstract][Full Text] [Related]
32. A high-throughput fluorescence resonance energy transfer (FRET)-based endothelial cell apoptosis assay and its application for screening vascular disrupting agents.
Zhu X; Fu A; Luo KQ
Biochem Biophys Res Commun; 2012 Feb; 418(4):641-6. PubMed ID: 22290227
[TBL] [Abstract][Full Text] [Related]
33. Development and Validation of a Universal High-Throughput UDP-Glycosyltransferase Assay with a Time-Resolved FRET Signal.
Zielinski T; Reichman M; Donover PS; Lowery RG
Assay Drug Dev Technol; 2016 May; 14(4):240-51. PubMed ID: 27136323
[TBL] [Abstract][Full Text] [Related]
34. HTS driven by fluorescence lifetime detection of FRET identifies activators and inhibitors of cardiac myosin.
Muretta JM; Rajasekaran D; Blat Y; Little S; Myers M; Nair C; Burdekin B; Yuen SL; Jimenez N; Guhathakurta P; Wilson A; Thompson AR; Surti N; Connors D; Chase P; Harden D; Barbieri CM; Adam L; Thomas DD
SLAS Discov; 2023 Jul; 28(5):223-232. PubMed ID: 37307989
[TBL] [Abstract][Full Text] [Related]
35. [High-throughput screening for hamster chymase 2 inhibitors].
Wang SB; Zhu XM; Gao F; Pang XB; Du GH
Yao Xue Xue Bao; 2012 Feb; 47(2):168-73. PubMed ID: 22512026
[TBL] [Abstract][Full Text] [Related]
36. [High-throughput screening of human soluble epoxide hydrolase inhibitors].
Wang SB; Guo J; Yu XM; Du GH
Yao Xue Xue Bao; 2010 Nov; 45(11):1367-72. PubMed ID: 21361036
[TBL] [Abstract][Full Text] [Related]
37. Development of a High-Throughput Cul3-Keap1 Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) Assay for Identifying Nrf2 Activators.
Poore DD; Hofmann G; Wolfe LA; Qi H; Jiang M; Fischer M; Wu Z; Sweitzer TD; Chakravorty S; Donovan B; Li H
SLAS Discov; 2019 Feb; 24(2):175-189. PubMed ID: 30383469
[TBL] [Abstract][Full Text] [Related]
38. Design of FRET-based GFP probes for detection of protease inhibitors.
Zhang B
Biochem Biophys Res Commun; 2004 Oct; 323(2):674-8. PubMed ID: 15369803
[TBL] [Abstract][Full Text] [Related]
39. Discovery of novel inhibitors of a disintegrin and metalloprotease 17 (ADAM17) using glycosylated and non-glycosylated substrates.
Minond D; Cudic M; Bionda N; Giulianotti M; Maida L; Houghten RA; Fields GB
J Biol Chem; 2012 Oct; 287(43):36473-87. PubMed ID: 22927435
[TBL] [Abstract][Full Text] [Related]
40. Synthetic substrate for application in both high and low throughput assays for botulinum neurotoxin B protease inhibitors.
Salzameda NT; Barbieri JT; Janda KD
Bioorg Med Chem Lett; 2009 Oct; 19(20):5848-50. PubMed ID: 19747823
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
